The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)

Clinical trial NCT04166838 · UNKNOWN

Trial details

NCT number: NCT04166838
Sponsor: Shanghai Longyao Biotechnology Inc., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia (B-ALL)Safety and Efficacy of CD19 UCAR-T Cells

Start date: 2019-11-08
Primary completion: 2019-11-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.